What was Steminent Biotherapeutics, Inc.’s price range in the past 12 months?
Steminent Biotherapeutics, Inc. lowest stock price was TWD 37.58 and its highest was TWD 240.00 in the past 12 months.
What is Steminent Biotherapeutics, Inc.’s market cap?
Steminent Biotherapeutics, Inc.’s market cap is TWD 15.13B.
When is Steminent Biotherapeutics, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Steminent Biotherapeutics, Inc. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Steminent Biotherapeutics, Inc. pay dividends?
Steminent Biotherapeutics, Inc. does not currently pay dividends.
What is Steminent Biotherapeutics, Inc.’s EPS estimate?
Steminent Biotherapeutics, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Steminent Biotherapeutics, Inc. have?
Steminent Biotherapeutics, Inc. has 80,682,240 shares outstanding.
Which hedge fund is a major shareholder of Steminent Biotherapeutics, Inc.?
Currently, no hedge funds are holding shares in TW:7729
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Steminent Biotherapeutics, Inc.
Steminent Biotherapeutics Inc. is a biopharmaceutical company dedicated to pioneering novel cellular therapeutics, with a primary focus on the research and development of innovative stem cell drugs. Their flagship product is Stemchymal, which is recognized for its significant therapeutic benefits and broad range of potential applications. The firm was established on December 18, 2007, and operates from its headquarters in Taipei, Taiwan.